Isotretinoin and psychopathology: a review - PubMed (original) (raw)

Isotretinoin and psychopathology: a review

Vassilis P Kontaxakis et al. Ann Gen Psychiatry. 2009.

Abstract

Isotretinoin, a synthetic oral retinoid that is used against severe nodulocystic acne, has been associated with various psychiatric side effects such as depression, suicidality and psychotic symptoms. A great number of reports on its effects have been published since its introduction into the market. However, a causal relationship has not been established and the link between isotretinoin use and psychiatric events remains controversial. The present paper reviews the available evidence regarding the association of isotretinoin and psychiatric side effects. All published material reporting psychiatric side effects following isotretinoin treatment, including case reports, case series, reports from adverse drug event reporting systems, prospective surveys and retrospective case-control studies, are presented. In addition, the neurobiology of the retinoids and possible biological mechanisms that may lead to psychopathology are described.

PubMed Disclaimer

Similar articles

• Isotretinoin and the controversy of psychiatric adverse effects.
  Strahan JE, Raimer S. Strahan JE, et al. Int J Dermatol. 2006 Jul;45(7):789-99. doi: 10.1111/j.1365-4632.2006.02660.x. Int J Dermatol. 2006. PMID: 16863513 Review.
• Psychiatric disorders, acne and systemic retinoids: comparison of risks.
  Le Moigne M, Bulteau S, Grall-Bronnec M, Gerardin M, Fournier JP, Jonville-Bera AP, Jolliet P, Dreno B, Victorri-Vigneau C. Le Moigne M, et al. Expert Opin Drug Saf. 2017 Sep;16(9):989-995. doi: 10.1080/14740338.2017.1344641. Epub 2017 Jul 12. Expert Opin Drug Saf. 2017. PMID: 28657366
• Psychiatric Adverse Events in Patients Taking Isotretinoin as Reported in a Food and Drug Administration Database From 1997 to 2017.
  Singer S, Tkachenko E, Sharma P, Barbieri JS, Mostaghimi A. Singer S, et al. JAMA Dermatol. 2019 Oct 1;155(10):1162-1166. doi: 10.1001/jamadermatol.2019.1416. JAMA Dermatol. 2019. PMID: 31268488 Free PMC article.
• Isotretinoin-induced psychotic episode in a 17-year-old adolescent male.
  Elhusein B, Elkhaled W, Khoodoruth MAS, Kumar R, Al Abdulla M. Elhusein B, et al. SAGE Open Med Case Rep. 2020 Jun 20;8:2050313X20931342. doi: 10.1177/2050313X20931342. eCollection 2020. SAGE Open Med Case Rep. 2020. PMID: 32612830 Free PMC article.
• Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris.
  Suuberg A. Suuberg A. Curr Ther Res Clin Exp. 2019 Feb 10;90:27-31. doi: 10.1016/j.curtheres.2019.01.008. eCollection 2019. Curr Ther Res Clin Exp. 2019. PMID: 30828405 Free PMC article. Review.

Cited by

• Isotretinoin and neuropsychiatric side effects: Continued vigilance is needed.
  Bremner JD. Bremner JD. J Affect Disord Rep. 2021 Dec;6:100230. doi: 10.1016/j.jadr.2021.100230. Epub 2021 Sep 10. J Affect Disord Rep. 2021. PMID: 37168254 Free PMC article.
• Treatment Options for Juvenile Pityriasis Rubra Pilaris.
  Guenther J, Novack D, Kamath S, Worswick S. Guenther J, et al. Paediatr Drugs. 2023 Mar;25(2):151-164. doi: 10.1007/s40272-022-00549-4. Epub 2022 Dec 18. Paediatr Drugs. 2023. PMID: 36529810 Review.
• The effects of isotretinoin on serotonin: a prospective pilot study on acne patients.
  Bray AP, Kravvas G, Skevington SM, Lovell CR. Bray AP, et al. An Bras Dermatol. 2022 Jul-Aug;97(4):526-528. doi: 10.1016/j.abd.2021.02.011. Epub 2022 May 30. An Bras Dermatol. 2022. PMID: 35654653 Free PMC article. No abstract available.
• Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data.
  Paljarvi T, McPherson T, Luciano S, Herttua K, Fazel S. Paljarvi T, et al. Br J Dermatol. 2022 Jul;187(1):64-72. doi: 10.1111/bjd.21049. Epub 2022 Apr 12. Br J Dermatol. 2022. PMID: 35174880 Free PMC article.
• Isotretinoin Use and Risk of Depression in Acne Vulgaris Patients in Riyadh, Saudi Arabia.
  AlGhofaili FA. AlGhofaili FA. Cureus. 2021 Mar 3;13(3):e13680. doi: 10.7759/cureus.13680. Cureus. 2021. PMID: 33833906 Free PMC article.

References

1. 1. Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol. 2001;45:S150–S157. doi: 10.1067/mjd.2001.113717. - DOI - PubMed
2. 1. Hanson N, Leachman S. Safety issues in isotretinoin therapy. Semin Cutan Med Surg. 2001;20:166–183. doi: 10.1053/sder.2001.28209. - DOI - PubMed
3. 1. Charakida A, Mouser PE, Chu AC. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin Drug Saf. 2004;3:119–129. doi: 10.1517/14740338.3.2.119. - DOI - PubMed
4. 1. Meyskens FL. Short clinical reports. J Am Acad Dermatol. 1982;6:732. doi: 10.1016/S0190-9622(82)80054-6. - DOI - PubMed
5. 1. Hazen PG, Carney JF, Walker AE, Stewart JJ. Depression – a side effect of 13-cis-retinoic acid therapy. J Am Acad Dermatol. 1983;9:278–279. - PubMed

LinkOut - more resources

• Full Text Sources

  • BioMed Central
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database